Aims and Scope of Bioorganic and Medicinal Chemistry Letters
Bioorganic & Medicinal Chemistry Letters is a scientific journal focusing on the results of research on the molecular structure of biological organisms and the interaction of biological targets with chemical agents. It is published by Elsevier, which also publishes Bioorganic & Medicinal Chemistry for longer works. Less
Key Metrics
CiteScore 

5
Impact Factor 

< 5
SJR 

Q3Biochemistry

SNIP 

0.75
Recommended pre-submission checks
Powered by 

Topics Covered on Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | PERGAMON-ELSEVIER SCIENCE LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details |
View less
Planning to publish in Bioorganic and Medicinal Chemistry Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Bioorganic and Medicinal Chemistry Letters
Synthesis and preliminary biological evaluation of resveratrol-like carbostyril derivatives as sirtuin 1 modulators and cyclooxygenase inhibitors.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
Site-specific profiling of lysine itaconylation via a thiol-based probe.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
Synthesis and biological investigation of phenothiazine-based derivatives as potential HDAC6 inhibitors for treatment of glioblastoma multiforme.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
99ᵐTc-DTPA-OM: Cardiac-myosin targeted SPECT agent for non-invasive myocardial infarction imaging.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
Identification of TYK2 activators. Part 2: Optimization of terminal alkyne substituents to enhance activation potency.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
Development of a novel PI3Kα/CDK7 potent hybrid inhibitor for Cancer treatment.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
Synthesis and preliminary biological evaluation of resveratrol-like carbostyril derivatives as sirtuin 1 modulators and cyclooxygenase inhibitors.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
Site-specific profiling of lysine itaconylation via a thiol-based probe.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
Synthesis and biological investigation of phenothiazine-based derivatives as potential HDAC6 inhibitors for treatment of glioblastoma multiforme.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
99ᵐTc-DTPA-OM: Cardiac-myosin targeted SPECT agent for non-invasive myocardial infarction imaging.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
Identification of TYK2 activators. Part 2: Optimization of terminal alkyne substituents to enhance activation potency.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters
Development of a novel PI3Kα/CDK7 potent hybrid inhibitor for Cancer treatment.
- 1 Nov 2026
- Bioorganic & medicinal chemistry letters